Literature DB >> 17981758

FGF signaling: its role in bone development and human skeleton diseases.

Nan Su1, XiaoLan Du, Lin Chen.   

Abstract

Fibroblast growth factors (FGFs)/Fibroblast growth factor receptors (FGFRs) signaling has recently been found to play very important roles in bone development and diseases. Missense mutations in several FGFs and FGFRs were found in human to cause a variety of congenital bone diseases including chondrodysplasia syndromes, craniosynostosis syndromes, and syndromes with dysregulated phosphate metabolism, etc. In addition to its role in bone development and genetic diseases, FGF signaling is also involved in the maintenance of adult bone homeostasis and fracture healing, etc. Understanding the underlying molecular mechanisms for the role of FGFs/FGFRs in the regulation of bone development and diseases will ultimately lead to better prevention and treatment of FGF signaling-related bone diseases. In this review, we are going to give a summary of the role of FGFs/FGFRs in skeleton development and diseases, and pay more attention to those recent progresses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981758     DOI: 10.2741/2890

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  28 in total

Review 1.  Syndromic craniosynostosis, fibroblast growth factor receptor 2 (FGFR2) mutations, and sacrococcygeal eversion presenting as human tails.

Authors:  C Corbett Wilkinson; David K Manchester; Robert F Keating; Lawrence L Ketch; Ken R Winston
Journal:  Childs Nerv Syst       Date:  2012-06-04       Impact factor: 1.475

2.  Localized all-cell knock-out (LACKO) strategy is needed for studying adult stage diseases.

Authors:  Xiaolan Du; Ying Zhu; Fengtao Luo; Lin Chen
Journal:  Transgenic Res       Date:  2012-06-14       Impact factor: 2.788

3.  Mechanism of shortened bones in mucopolysaccharidosis VII.

Authors:  Jason A Metcalf; Yanming Zhang; Matthew J Hilton; Fanxin Long; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-03-25       Impact factor: 4.797

4.  Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.

Authors:  Qing He; Xuehui Yang; Yan Gong; Dmitry Kovalenko; Ernesto Canalis; Clifford J Rosen; Robert E Friesel
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

5.  Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix.

Authors:  Juliya Kalinina; Sara A Byron; Helen P Makarenkova; Shaun K Olsen; Anna V Eliseenkova; William J Larochelle; Mohanraj Dhanabal; Steven Blais; David M Ornitz; Loren A Day; Thomas A Neubert; Pamela M Pollock; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

6.  Image Diagnosis: Disappearing Digits: Metabolic Bone Disease in End-Stage Renal Disease.

Authors:  Shitij Arora; Fathima Jahufar
Journal:  Perm J       Date:  2019-05-17

7.  The pathology of bone tissue during peri-implantitis.

Authors:  B Schminke; F Vom Orde; R Gruber; H Schliephake; R Bürgers; N Miosge
Journal:  J Dent Res       Date:  2014-11-18       Impact factor: 6.116

8.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

Authors:  Nan Su; Qidi Sun; Can Li; Xiumin Lu; Huabing Qi; Siyu Chen; Jing Yang; Xiaolan Du; Ling Zhao; Qifen He; Min Jin; Yue Shen; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

9.  FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion.

Authors:  Masayo Harada; Hirotaka Murakami; Akihiko Okawa; Noriaki Okimoto; Shuichi Hiraoka; Taka Nakahara; Ryogo Akasaka; Yo-Ichi Shiraishi; Noriyuki Futatsugi; Yoko Mizutani-Koseki; Atsushi Kuroiwa; Mikako Shirouzu; Shigeyuki Yokoyama; Makoto Taiji; Sachiko Iseki; David M Ornitz; Haruhiko Koseki
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

10.  Generation of Fgfr3 conditional knockout mice.

Authors:  Nan Su; Xiaoling Xu; Cuiling Li; Qifen He; Ling Zhao; Can Li; Siyu Chen; Fengtao Luo; Lingxian Yi; Xiaolan Du; Haiyang Huang; Chuxia Deng; Lin Chen
Journal:  Int J Biol Sci       Date:  2010-06-15       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.